Ms Contin Cr | Morphine Sulfate Tablet, Film Coated, Extended Release while Breastfeeding

What is Ms Contin Cr | Morphine Sulfate Tablet, Film Coated, Extended Release used for?

Is using Ms Contin Cr | Morphine Sulfate Tablet, Film Coated, Extended Release safe or dangerous while breastfeeding?

Morphine sulfate while Breastfeeding

CAS Number: 57-27-2

Excretion into breast milk is low (even lower when administered through Epidural Anesthesia). In addition, a low oral bioavailability makes that the amount present in the infant's plasma due to absorption from milk by the gut is low. Even though, level of drug has been found in the plasma of infants from treated mothers, harmful effects in the infants were not reported. Levels in the milk are lower and side-effects are fewer among infants whose mothers were treated with Morphine than with Pethidine. Some authorities consider Morphine as the elective opioid medication for breastfeeding mothers. Analgesia used during the birth process is related to a brief delayed of stage II of Lactogenesis (milk come-in). Morphine increases Prolactin level and may decrease Oxytocin level, but it would not be determinant for already established lactations. Avoidance of repetitive or chronic use and follow-up for somnolence and adequacy of infant nourishment is recommended. Bed-sharing should be avoid whenever this medication is used by parents. The American Academy of Pediatrics rates it as compatible with breastfeeding.

Morphine sulfate while Breastfeeding

CAS Number: 57-27-2

Epidural morphine given to mothers for postcesarean section analgesia results in trivial amounts of morphine in their colostrum and milk. Intravenous or oral doses of maternal morphine in the immediate postpartum period result in higher milk levels than with epidural morphine. Labor pain medication may delay the onset of lactation. Maternal use of oral narcotics during breastfeeding can cause infant drowsiness, central nervous system depression and even death, although low-dose morphine might be preferred over other opiates.[1] Newborn infants seem to be particularly sensitive to the effects of even small dosages of narcotic analgesics. Once the mother's milk comes in, it is best to provide pain control with a nonnarcotic analgesic and limit maternal intake of morphine to a 2 to 3 days at a low dosage with close infant monitoring, especially in the outpatient setting.[2] If the baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing difficulties, or limpness, a physician should be contacted immediately.

What should I do if I am breastfeeding mother and I am already exposed to Ms Contin Cr | Morphine Sulfate Tablet, Film Coated, Extended Release?

My doctor has prescribed me Ms Contin Cr | Morphine Sulfate Tablet, Film Coated, Extended Release, what should I do?

If I am using Ms Contin Cr | Morphine Sulfate Tablet, Film Coated, Extended Release, will my baby need extra monitoring?

Who can I talk to if I have questions about usage of Ms Contin Cr | Morphine Sulfate Tablet, Film Coated, Extended Release in breastfeeding?